These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 8873633

  • 1. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC, Moher D, Barber GG.
    CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633
    [Abstract] [Full Text] [Related]

  • 2. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr 15; 18(100):56-9. PubMed ID: 19585717
    [Abstract] [Full Text] [Related]

  • 3. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Apr 15; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

  • 4. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial.
    Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, De Sanctis MT, Incandela L, Geroulakos G, Ramaswami G, Cazaubon M, Barsotti A, Vasdekis S, Bavera P, Ippolito E.
    Angiology; 2002 Apr 15; 53 Suppl 1():S1-5. PubMed ID: 11865828
    [Abstract] [Full Text] [Related]

  • 5. Cilostazol for intermittent claudication.
    Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis DP, Stansby G.
    Cochrane Database Syst Rev; 2014 Oct 31; 2014(10):CD003748. PubMed ID: 25358850
    [Abstract] [Full Text] [Related]

  • 6. Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses.
    Gillings DB.
    J Cardiovasc Pharmacol; 1995 Oct 31; 25 Suppl 2():S44-50. PubMed ID: 8699861
    [Abstract] [Full Text] [Related]

  • 7. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Oct 31; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [Abstract] [Full Text] [Related]

  • 8. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar 31; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 9. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL, Gelso E.
    Drugs Exp Clin Res; 2002 Mar 31; 28(1):37-48. PubMed ID: 12073766
    [Abstract] [Full Text] [Related]

  • 10. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG, Pini M, Moratti A, Paolicelli M, Basevi P, Quintavalla R, Manotti C, Di Lecce C.
    Angiology; 1989 Apr 31; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [Abstract] [Full Text] [Related]

  • 11. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 31; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 12. Pentoxifylline for intermittent claudication.
    Broderick C, Forster R, Abdel-Hadi M, Salhiyyah K.
    Cochrane Database Syst Rev; 2020 Oct 16; 10(10):CD005262. PubMed ID: 33063850
    [Abstract] [Full Text] [Related]

  • 13. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials.
    Radack K, Deck C.
    Arch Intern Med; 1991 Sep 16; 151(9):1769-76. PubMed ID: 1679624
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
    Moody AP, al-Khaffaf HS, Lehert P, Harris PL, Charlesworth D.
    J Cardiovasc Pharmacol; 1994 Sep 16; 23 Suppl 3():S44-7. PubMed ID: 7517477
    [Abstract] [Full Text] [Related]

  • 15. Pentoxifylline for intermittent claudication.
    Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA.
    Cochrane Database Syst Rev; 2015 Sep 29; 9(9):CD005262. PubMed ID: 26417854
    [Abstract] [Full Text] [Related]

  • 16. Pentoxifylline for intermittent claudication.
    Salhiyyah K, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA.
    Cochrane Database Syst Rev; 2012 Jan 18; 1():CD005262. PubMed ID: 22258961
    [Abstract] [Full Text] [Related]

  • 17. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group.
    Thromb Haemost; 2001 Nov 18; 86(5):1181-7. PubMed ID: 11816704
    [Abstract] [Full Text] [Related]

  • 18. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R, Walker S, MacSweeney S.
    Curr Med Res Opin; 2001 Nov 18; 17(2):113-5. PubMed ID: 11759179
    [Abstract] [Full Text] [Related]

  • 19. [Pentoxifylline and intermittent claudication: critical analysis of clinical trials].
    Charansonney OL, Spriet A.
    Therapie; 1995 Nov 18; 50(1):73-8. PubMed ID: 7754482
    [Abstract] [Full Text] [Related]

  • 20. Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis.
    Girolami B, Bernardi E, Prins MH, ten Cate JW, Prandoni P, Hettiarachchi R, Marras E, Stefani PM, Girolami A, Büller HR.
    Thromb Haemost; 1999 May 18; 81(5):715-22. PubMed ID: 10365743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.